Ginkgo Bioworks Holdings Inc (NYSE:DNA)’s traded shares stood at 43.71 million during the last session, with the company’s beta value hitting 1.41. At the close of trading, the stock’s price was $0.87, to imply a decrease of -4.59% or -$0.04 in intraday trading. The DNA share’s 52-week high remains $2.55, putting it -193.1% down since that peak but still an impressive -3.45% since price per share fell to its 52-week low of $0.90. The company has a valuation of $1.77B, with an average of 22.67 million shares over the past 3 months.

Ginkgo Bioworks Holdings Inc (NYSE:DNA) trade information

After registering a -4.59% downside in the last session, Ginkgo Bioworks Holdings Inc (DNA) has traded red over the past five days. The stock hit a weekly high of 1.1500, dropping -4.59% in its intraday price action. The 5-day price performance for the stock is -22.18%, and -20.04% over 30 days. With these gigs, the year-to-date price performance is -48.43%.

Ginkgo Bioworks Holdings Inc (DNA) estimates and forecasts

Looking at statistics comparing Ginkgo Bioworks Holdings Inc share performance against respective industry, we note that the company has outperformed competitors. Ginkgo Bioworks Holdings Inc (DNA) shares are -48.12% down over the last 6 months, with its year-to-date growth rate higher than industry average at 17.95% against 12.80%.

DNA Dividends

Ginkgo Bioworks Holdings Inc has its next earnings report out between March 01 and March 05. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Ginkgo Bioworks Holdings Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.